NL-OMON53540招募中不适用
TOwaRds PrEcision Dosing of Olanzapine in anorexia nervosa patients - TORPEDO
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 12 至 64（—）
入选标准
- •Age 12 to 30 years
- •Diagnosis according to DSM-5 criteria for anorexia nervosa
- •Documented clinical indication for treatment with olanzapine
- •Treatment with olanzapine (including current users and recent starters)
- •Signed informed consent
- •Non-AN group
- •Age 12 to 30 years
- •Documented clinical indication for treatment with olanzapine
- •Treatment with olanzapine (including current users and recent starters)
- •Signed informed consent
排除标准
- •Co-medications: carbamazepine, lopinavir, rifampicin, ritonavir,
- •ciprofloxacin and fluvoxamine.
- •Pregnancy
- •The congenital or acquired syndrome is associated with changes in appetite,
- •body weight, or lipid profile (e.g. Prader Willi)
- •Non-AN group:
- •Diagnosis according to DSM-5 criteria for anorexia nervosa
- •Co-medications: carbamazepine, lopinavir, rifampicin, ritonavir,
- •ciprofloxacin and fluvoxamine.
- •Pregnancy
- •The congenital or acquired syndrome is associated with changes in appetite,
- •body weight, or lipid profile (e.g. Prader Willi)
研究者
相似试验
已完成
不适用
olanzapinein the treatment of anorexia nervosa: a system review and meta-analysisanorexia nervosaJPRN-UMIN000043186Beijing Huilong guan Hospital40
已完成
不适用
Olanzapine Versus Placebo for Outpatients With Anorexia NervosaAnorexia NervosaNCT01170117New York State Psychiatric Institute152
进行中（未招募）
不适用
Olanzapine for young people with anorexia nervosaAnorexia nervosa (AN)Mental and Behavioural DisordersAnorexia nervosaISRCTN80075010King's College London55
已完成
2 期
Effectiveness of Olanzapine Versus Placebo in Treating Outpatients With Anorexia NervosaEating DisordersNCT00692185New York State Psychiatric Institute23
尚未招募
2 期
Comparing olanzapine with inactive drug for loss of appetiteCTRI/2023/09/057403Jefrilla Nancy J